Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 96
Appendix B
Public Meeting Agenda
July 1 1' 2002
Immunization Safety Review Committee
SV40 Contamination of Polio Vaccine and Cancer
National Academy of Sciences Main Building
Lecture Hall, 2100 C St, NW
Washington DC
8:45-9:00 am
Welcome and Opening Remarks
Marie McCormick, MD, ScD
Committee Chair
9:00-9:15 am Brief History and Important Questions
William Egan, PhD, CBER, FDA
9:15-11:15 am Epidemiological Evidence Regarding Causality
Between SV40-contaminated Polio Vaccines and
Human Cancers
Howard Striclder, MO, MPH
Albert Einstein College of Medicine
Susan Fisher, MD, University of Rochester
Eric Engels' MD, ASH, NCI, NIH
11:15-11:30 am
Break
96
OCR for page 97
APPENDIX B 97
11:30-12:45 pm SV40 Detection and Transmission
Keerti Shah, MD, DrPH
Johns Hopkins Bloomberg School of Public Health
Jeffrey Kopp, MD, NIDDK, NIH
12:45-1:45 pm Lunch
1:45-4:15 pm The Presence and Mechanisms of SV40
in Human Cancers
Janet Butel, PhD
Baylor University School of Medicine
Michele Carbone, MD, PhD
Loyola University School of Medicine
4:15pm
5:30 pm
Discussion and Public Comment
Adjourn
Representative terms from entire chapter:
evidence regarding
